CD274 and neoplasm: In patients where the GC was scored as CPS ≥ 1 in all three tumour locations, 74.0% of primary GC, 58.8% of lymph node metastases and 25.0% of distant metastases showed no PD-L1 expression in tumour cells (Table 1).